Order Article Reprints

Berg CJ, Abroms LC, Levine H, Romm KF, Khayat A, Wysota CN, Duan Z, Bar-Zeev Y. IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers. International Journal of Environmental Research and Public Health. 2021; 18(19):10551. https://doi.org/10.3390/ijerph181910551

Berg, Carla J., Lorien C. Abroms, Hagai Levine, Katelyn F. Romm, Amal Khayat, Christina N. Wysota, Zongshuan Duan, and Yael Bar-Zeev. 2021. "IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers" International Journal of Environmental Research and Public Health 18, no. 19: 10551. https://doi.org/10.3390/ijerph181910551

Berg, C. J., Abroms, L. C., Levine, H., Romm, K. F., Khayat, A., Wysota, C. N., Duan, Z., & Bar-Zeev, Y. (2021). IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers. International Journal of Environmental Research and Public Health, 18(19), 10551. https://doi.org/10.3390/ijerph181910551